119 results about "Phenoxazine" patented technology

The invention relates to a phenoxazine dye and a photoelectric converter using the dye, and belongs to the technology field of phenoxazine dyes. The technical proposal is that: the chemical structure of the dye contains substituted phenoxazine and the derivative thereof as electron donors and different conjugated groups as bridging chains, wherein one end of the bridging chains are connected with different electron-withdrawing groups. An electron-donating group on a nitrogen atom and lone-pair electrons on an oxygen atom interact with a chromophoric conjugated system, thereby resulting in more easier charge transfer of the excited state of molecules and generating unique photoelectric property. The phenoxazine dye has good application performance in dye-sensitized solar cells, and can replace expensive noble metal photosensitive dye in dye-sensitized solar cells.

The invention discloses a preparation method and applications of hexatomic dinitrogen heterocyclic derivatives containing four identical substituent groups, and belongs to the field of application technology of luminescent materials in preparation of organic light-emitting devices. According to the preparation method, pyrazine and pyridazine are taken as electron acceptors of luminescent materials; the periphery of the electron acceptors is connected with electron donors such as carbazole, phenoxazine, and 9,9-dimethyl-9,10-dihydracridine; frontal orbital overlapping degree of HOMO and LUMO is adjusted, so that luminescent materials with thermally activated delayed fluorescence (TADF) characteristics are obtained. At room temperature, the hexatomic dinitrogen heterocyclic derivatives possess strong absorption at ultraviolet-visible region, a dilute solution of the hexatomic dinitrogen heterocyclic derivatives is capable of emitting strong fluorescence, the wavelength of emission peaks ranges from 450 to 615nm in the blue light-orange light range, the hexatomic dinitrogen heterocyclic derivatives can be applied to organic light-emitting devices as luminescent materials. According to devices based on compound M2, turn-on voltage is 3.9V, the maximum brightness 3846cdm<2> is achieved at a voltage of 12V; and the maximum luminous efficiency 17.4cdA<1> and the maximum power efficiency 12.21mW<1> are achieved when electric current density is 0.06mAcm<2>(4.5V).

The invention relates to a crosslinkable organic molecule having a structure of the formula (1) and to the use thereof, wherein Ar is independently of one another, an unsaturated or aromatic carbo- or heterocyclic unit with 5 to 30 ring atoms, selected from the group consisting of naphthalene, anthracene, phenanthrene, pyrene, dihydropyrene, chrysene, perylene, fluoranthene, benzanthracene, tetracene, pentacene, benzpyrene, furan, benzofuran, isobenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazol, naphthimidazole, phenanthrimidazole, pyridimidazole, pyrazine-imidazole, quinoxalinimidazole, oxazole, benzoxazole, naphthoxazole, anthroxazole, phenanthroxazole, isoxazole, isothiazole, 1,3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzpyrimidine, quinoxaline, pyrazine, phenazine, naphthyridine, azacarbazole, benzocarboline, phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, tetrazole, 1,2,3,4- oxatriazole, 1,2,3,4-oxatriazole, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazin, purine, pteridine, indolizine, benzothiadiazole, indenocarbazole, indenofluorene, spirobifluorene, and indolocarbazole; D1 is a donor group having a structure of the formula (1a); and D2 is a donor group having a structure of the formula (1b).

The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.

The invention relates to a chiral thermal activation delayed fluorescence material and a preparation method thereof. The delayed fluorescence material is R / S-18,21-di(10H-phenoxazine-10-yl)-3,4,5,6,7,8,9,10-octahydrodibenzo[a,c]dinaphtho[2',1':5,6;1',2'':7,8][1,4]dioxin[2,3i]phenazine, or R / S-16,17-bis(4-(10H-phenoxazine-10-yl)phenyl)3,4,5,6,7,8,9,10-octahydronaphthalo[2',1':5,6; 1',2'':7,8][1,4]dioxane[2,3g] quinoxaline. The compound provided by the invention has the characteristics of a rigid large-plane twisted structure and a remarkable internal charge transfer (ICT) effect, and has the advantages of typical thermal activation delayed fluorescence (TADF) property, circular polarization (CPL) property, high fluorescence quantum yield (PLQY), good thermal stability and the like. The method has the advantages of few synthesis and preparation steps, readily available raw materials, simple synthesis and purification processes and high yield, and can be used for large-scale synthesis andpreparation.

Dye-sulfenate derivatives and their bioconjugates for dual phototherapy of tumors and other lesions. The compounds comprise sulfenates having the formula, t,0080where E is selected from the group consisting of somatostatin receptor binding molecules, heat sensitive bacterioendotoxin receptor binding molecules, neurotensin receptor binding molecules, bombesin receptor binding molecules, cholecystekinin receptor binding molecules, steroid receptor binding molecules, and carbohydrate receptor binding molecules, and dihydoxyindolecarboxylic acid; L and X are independently selected from the group consisting of —(R5)NOC—, —(R5)NOCCH2O—, —(R5)NOCCH2CH2O—, —OCN(R5)—, —HNC(═S)NH—, and HNC(═O)NH—; DYE is an aromatic or a heteroaromatic radical derived from the group consisting of cyanines, indocyanines, phthalocyanines, rhodamines, phenoxazines, phenothiazines, phenoselenazines, fluoresceins, porphyrins, benzoporphyrins, squaraines, corrins, croconiums, azo dyes, methine dyes, indolenium dyes, crellins, and hypocrellins; R1 to R5 are independently selected from the group comprising hydrogen, C1-C10 alkyl, C5-C10 aryl, C1-C10 polyhydroxyalkyl, and C1-C10 polyalkoxyalkyl; and Ar is an aromatic or heteroaromatic radical derived from the group consisting of benzenes, naphthalenes, naphthoquinones, diphenylmethanes, fluorenes, anthracenes, anthraquinones, phenanthrenes, tetracenes, naphthacenediones, pyridines, quinolines, isoquinolines, indoles, isoindoles, pyrroles, imidiazoles, oxazoles, thiazoles, pyrazoles, pyrazines, purines, benzimidazoles, furans, benzofurans, dibenzofurans, carbazoles, acridines, acridones, phenanthridines, thiophenes, benzothiophenes, dibenzothiophenes, xanthenes, xanthones, flavones, coumarins, and anthacylines. The compounds are designed to produce both Type 1 and Type 2 phototherapeutic effects at once using a dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest.

The invention relates to the technical field of phenoxazine derivatives, and particularly relates to 3,7-disubstituted phenoxazine derivatives and a preparation method thereof. Phenoxazine adopted asa raw material is subjected to a coupling reaction to synthesize N-(4-aminophenyl) phenoxazine; the N-(4-aminophenyl) phenoxazine is subjected to a nitration reaction to synthesize 3,7-dinitro-N-(4-nitrophenyl) phenoxazine; the 3,7-dinitro-N-(4-nitrophenyl) phenoxazine is subjected to reduction to synthesize 3,7-diamino-N-(4-aminophenyl) phenoxazine. The obtained 3,7-dinitro-N-(4-nitrophenyl) phenoxazine and the 3,7-diamino-N-(4-aminophenyl) phenoxazine can be structurally modified easily, and novel compounds having different functions can be easily synthesized from the same. The synthesized phenoxazine derivatives can be widely applied in materials, dye, photosensitized solar cells, and other fields.

A blue electroluminescent polymer having a phenoxazine-based unit in a polyarylene backbone and an organic electroluminescent device using the polymer. The organic electroluminescent device has improved luminous efficiency and color purity.

The invention relates to the phenoxazine compounds of formulae I, and the pharmaceutical acceptable salts, esters, amides and prodrugs thereof, to the pharmaceutical compositions containing them, to the use of the preparation of the medicines for inhibiting the starchy protein coagulate. The definitions of R1, R2 and R in formulae I are described in the specification.

The invention discloses a phenoxazine-based two-dimensional covalent organic framework material and a preparation method and application thereof. The phenoxazine-based two-dimensional covalent organic framework material has a structure as shown in any one of the following formulas: the phenoxazine-based two-dimensional covalent organic framework material prepared by the invention has high crystallinity and specific surface area, uniform pore size distribution and better thermal stability; meanwhile, the phenoxazine-based two-dimensional covalent organic framework material has fluorescence emission with specific wavelength in an organic solvent, and the fluorescence emission intensity is related to the moisture content in the organic solvent. Therefore, the phenoxazine-based two-dimensional covalent organic framework material prepared by the method can be applied to detection of the moisture content in an organic solvent, and has a good application prospect in the field of functional organic materials.

The invention provides a spirofluorene and nitrogen-containing hetercyclic organic electroluminescent material and an organic luminescent device thereof and belongs to the technical field of organic photoelectric materials. The spirofluorene and nitrogen-containing hetercyclic organic electroluminescent material structurally contains a spirofluorene structure which is a blue-light structure with excellent property, not only has higher triplet energy level and wider energy gap, but also is higher in vitrifying conversion temperature and difficult in crystallization; by connection of groups suchas phenoxazine and phenothiazine and the like in molecules, the cavity transmission capability of the blue-light main body structure is added, so that the transportation of current carriers is balanced. Compared with the prior art, the spirofluorene and nitrogen-containing hetercyclic organic electroluminescent material is applied to the organic luminescent device, is especially used as a blue luminescent material in a luminescent layer and has relatively-higher luminescent efficiency.